Vincerx Pharma Inc (VINC)
0.8771
-0.05
(-5.69%)
USD |
NASDAQ |
May 03, 16:00
0.877
0.00 (0.00%)
After-Hours: 20:00
Vincerx Pharma Cash from Operations (TTM): -40.45M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -40.45M |
| September 30, 2023 | -46.25M |
| June 30, 2023 | -54.48M |
| March 31, 2023 | -57.67M |
| December 31, 2022 | -59.60M |
| September 30, 2022 | -57.27M |
| June 30, 2022 | -52.70M |
| Date | Value |
|---|---|
| March 31, 2022 | -44.99M |
| December 31, 2021 | -33.40M |
| September 30, 2021 | -24.05M |
| June 30, 2021 | -13.89M |
| March 31, 2021 | -5.716M |
| December 31, 2020 | -2.279M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-59.60M
Minimum
Dec 2022
-2.279M
Maximum
Dec 2020
-37.90M
Average
-44.99M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
| Trxade Health Inc | -2.074M |
| MyMD Pharmaceuticals Inc | -12.98M |
| Acrivon Therapeutics Inc | -42.64M |
| Ligand Pharmaceuticals Inc | 49.58M |
| Regulus Therapeutics Inc | -26.77M |